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1. Introduction 
For more than three decades, proteomics have been a crucial tool for deciphering the 
intricate molecular systems governing biology. O'Farrel was the first to utilise 2 dimensional 
gel electrophoresis (2DE) to perform actual complex proteomic analyses (O'Farrell, 1975). 
2DE has very quickly emerged at the forefront of this rapidly growing field of research and 
has allowed for thousands of studies in widely varied domains. The development of 2D 
Fluorescence Gel Electrophoresis (2D DIGE) has provided more accurate and reliable 
proteins quantification due to the simultaneous migration on a same gel of samples to be 
compared, avoiding gel-to-gel variation. More recently, technological improvements in 
liquid chromatography and mass spectrometry have made it possible to develop so called 
"gel-free proteomics" in which, after total proteome enzymatic digestion, the produced 
peptides are separated with a high resolution chromatographic system and identified using 
tandem mass spectrometry. A gel-free approach presents a number of advantages over 2DE, 
such as a higher sensitivity, an easier automation of procedures to provide a better 
reproducibility and a reduced influence of intrinsic protein characteristics (pI, molecular 
weight, etc.). Nevertheless, a high complementarity between 2DE and gel-free approaches 
has been extensively reported (Finamore et al., 2010; Charro et al., 2011; Matallana-Surget et 
al., submitted), which suggests that both methods will continue to be considered together 
for a long time. Furthermore, 2DE also presents some advantages over a gel-free workflow 
approach in particular contexts. Indeed, 2DE presents the important benefit of allowing for 
the detection of protein isoforms, which is still complicated using gel-free approaches. 
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Another example is an immunoproteomic workflow in which 2DE is followed by 
immunodetection, which allows for the targeted analysis and detection of antigen 
candidates.  
An additional important difference between gel-free approaches and gel-based workflow is 
found in the quality of the quantitative data obtained. Indeed, 2DE quantification relies on 
spot volume measurement, which implies each protein is quantified based on a single data 
point. In contrast, multiple peptides from the same protein can be used for quantification 
using gel-free approaches. This major difference clearly indicates that gel-free workflow-
derived quantitative data are more statistically robust. However, before gel-free workflow 
approaches can be used in differential proteomics, the intrinsic limitation of mass 
spectrometry-based peptide analyses, the ion suppression effect, must first be addressed. 
2. Ion suppression effect 
The ion suppression effect can be defined as a negative influence of the chemical 
environment of a compound upon its ionisation. In other words, in addition to the chemical 
characteristics of a compound, the molecules present around it during the ionisation process 
will influence its ionisation. Even if this phenomenon is also observed under MALDI 
conditions, this chapter will focus on electrospray ionisation (ESI)-based LC MS/MS 
workflow, and thus, only ESI ion suppression effects will be discussed here.  
Electrospray ionisation results from a complex process that is not fully understood today 
but most likely relies on ion ejection from a droplet due to electric field strength and on 
solvent evaporation leading to charge acquisition and gas phase transfer. More details on 
the ionisation principle are available in a recent review by Wilm (Wilm, 2011). The 
importance of ion suppression effects in ESI have been mainly investigated in toxicology 
analyses in the context of LC MS/MS detections and the quantification of target compounds 
in biological matrices. A mechanistic investigation in 2000 (King et al., 2000) concluded that 
the gas phase reaction of charge transfer was likely less important than the solution phase 
processes into ion suppression effect under electrospray conditions. The results of this study 
point out that the modification of small droplet formation due to non-volatile compounds is 
the main cause of ionisation suppression, given that other mechanisms can also play minor 
roles in analyte ionisation. Using LC MS/MS-based toxicological analyses of target 
compounds in biological matrices, Muller et al. (Muller et al., 2002) also confirmed that the 
majority of the observable ion suppression effect was limited to the early period of reverse 
phase (RP) chromatography when unretained polar compounds were present in the 
electrospray solution. In RP-LC MS/MS-based proteomic analyses, the ion suppression 
effect due to these unretained polar compounds should not be a major concern because 
peptides will generally be significantly slowed on a C18 reversed phase column and thus, 
not co-elute with such compounds. Nevertheless, the ion suppression effect also originates 
from in-solution competition between the co-eluting analytes for charge acquisition and gas 
phase ejection during ESI. This decreased ionisation efficiency is sometimes referred to as 
the matrix effect and can be understood using the equilibrium partitioning model (Enke, 
1997). The equilibrium partitioning model describes that ESI nano-droplets consist of two 
phases: an electrically neutral phase containing solvent molecules at its centre and an excess 
charge containing surface layer. An analyte is distributed between these two phases based 
on factors such as its hydrophobicity, its charge density or its basicity. Only analytes present 
at the surface layer will be amenable to ionisation and consequently, a competition can exist 
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between analytes for distribution in the charged surface. In other words, co-eluting 
compounds enter into a competition for this distribution and therefore, for ionisation. This 
model helps explain why the increased non-polar character of peptides, which leads to an 
increased affinity for the surface phase, results in a more successful competition for surface 
localisation and thus, ionisation (Cech and Enke, 2000). Ion suppression effects and in 
particular, the observed competition of co-eluting peptides for ionisation (the matrix effect) 
have made difficult the quantitative use of gel-free proteomic techniques. The first strategy 
to address this issue has been to analyse samples that have to be compared simultaneously 
after mixing them and thus, ensuring that the ionisation of the quantified peptides has been 
performed with exactly the same matrix effect. In order to achieve this goal, proteins or 
peptides from the samples that are to be compared are labelled using an isotopic coded tag 
that will not influence their behaviour during LC MS/MS but rather introduce a mass shift 
between samples that will allow the discrimination of the origin of the peptide. 
The second strategy for quantitative gel-free proteomics relies on an early demonstration 
(Voyksner and Lee, 1999) that peptide peak intensity correlates with its concentration in a 
sample and could thus be used to compare one run to another. Nevertheless, to analyse a 
complex peptide mixture, one must take into account the matrix effect. Indeed, in such a 
mixture, to be able to compare the run-to-run peak intensities of a peptide, one needs to be 
able to exactly reproduce the same chromatographic separation for all the samples that are 
being compared so that all the peptides are always ionised with the same co-eluting 
peptides. If this prerequisite is not satisfied, the competition between the peptides for 
ionisation will not be conserved, and a difference in ionisation efficiency will introduce 
biases into the quantitative data. This manner of interpreting data has led to the 
development of gel-free quantitative proteomics, which rely on a highly reproducible 
chromatographic separation and have developed very quickly since the recent apparition of 
ultra pressure chromatography. 
3. Quantification strategies 
Quantitative proteomic can be classified in two major approaches: the stable isotope 
labelling and the label-free techniques (Figure 1). 
3.1 Isotope-coded labelling 
As suggested above, isotope-coded labelling allows for mass shift introduction between the 
proteins/peptides of the samples to be compared, which makes it possible to mix them 
before an LC MS/MS analysis. As the peptides contained within the samples to be 
compared have been ionised under exactly the same conditions, their intensities can be 
compared in order to achieve a relative quantification. The first developed method based on 
this principle was ICAT (isotope-coded affinity tag;(Gygi et al., 1999)), which relies on 
cysteine tagging followed by the affinity-based enrichment of tagged peptides. Initially, the 
ICAT tag consisted of a biotin moiety used for affinity enrichment and a thiol-specific 
reactive group for cysteine labelling. These two groups were separated from each other by a 
linker group, which contained 8 hydrogens in the light tag and 8 deuteriums in the heavy 
tag (Gygi et al., 1999). Thus, this tag introduces a mass shift of 8 Da, which will allow the 
peptides in the samples to be distinguished from one another and compared based on their 
mass spectrum; this tag also makes it possible to measure the relative abundances of the 
corresponding proteins in the two samples. This strategy has been referred to as non- 
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Fig. 1. Schematic representation of the main quantification workflow. (a-e) Isotopic labelling 
relies on the introduction of a discriminative mass shift, which allows sample mixing before 
analyses with 2D-LC MS/MS. Quantitative data are obtained in the MS spectrum in the case 
of non-isobaric labelling (d) or in MS/MS mode due to the release of a reporter group upon 
fragmentation during isobaric labelling (e). Isotopic labelling can be performed at the 
protein (a), peptide (b) or cell culture level (c). (f-h) In a label-free workflow, samples are 
prepared and analysed separately by LC MS/MS (f). Quantitative data can be obtained 
either from the Area under the curve (AUC) calculated from an extracted ion chromatogram 
for the representative peptides of a protein (g) or from a number of matching MS/MS 
associated with a protein (h). 
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isobaric labelling. ICAT has been continuously improved by first replacing deuterium 
coding with the C13 isotope in order to minimise the chromatographic resolution of the 
isotope-coded peptides (Zhang and Regnier, 2002) and then introducing a disulphide bond 
in the linker so affinity-trapped labelled peptides can be more efficiently eluted from the 
avidin affinity matrix by reductive cleavage of the linker (Hansen et al., 2003). Several non-
isobaric tags have also been developed that similarly rely on the quantification of the 
peptides in the MS due to the isotopically introduced mass shift. 
Following the development of non-isobaric labelling, isobaric tags such as iTRAQ (isobaric 
tag for relative and absolute quantification) were introduced (Ross et al., 2004). Isobaric tags 
are composed of an amine-specific reactive group, which allows for the tagging of proteins 
on lysines and peptides on their N-termini and a reporter group that has a different isotopic 
composition when comparing the different versions of the tag and thus, different masses. A 
balance group, which has an isotopic composition complementary to the reporter so that the 
global mass of reporter + balance group is constant between the different versions of the tag, 
is placed between the reactive and the reporter group. Thus, the tagged peptides are not 
discriminated in the MS. Upon peptide fragmentation by MS/MS, the reporter group is 
released and appears in the low mass range of the MS/MS spectrum. Separated from their 
balance group, the reporter ions are distinguishable from each other because their different 
isotopic composition introduces a 1- Da mass shift between them. The relative abundance of 
the peptides/proteins in the samples to be compared is deduced from the relative 
abundance of the corresponding reporter ions. 
3.1.1 Non-isobaric labelling 
ICAT was the first commercially available isotopic-labelling reagent, with a thiol-specific tag 
to target low abundance amino acids and due to enrichment, enabling a significant decrease 
of sample complexity (Figure 1a). However, a significant proportion of proteins could not be 
quantified with ICAT because of a lack of cysteines and hence, a high number of proteins 
were only quantified based on single peptides. This main limitation, observed with ICAT 
technique, encouraged researchers to develop alternative tags. ICPL (isotope-coded protein 
labelling) is one of these tags and was mainly developed to solve the low sequence coverage 
drawback of ICAT (Schmidt et al., 2005). ICPL, an amine reactive tag targeting lysines on 
intact proteins, was supposed to address this issue and reduce the proportion of 
unquantifiable proteins by increasing the number of quantified peptides per protein 
(Schmidt et al., 2005). Using ICPL, we and other groups have demonstrated that an 
important proportion of identified peptides in trypsin digested samples still lack a lysine 
and were not tagged and not quantifiable (Mastroleo et al., 2009b; Paradela et al., 2009). In 
the protein-labelling conformation, ICPL only allows for the quantification of approximately 
70% of the identified proteins. Using the amine reactivity of ICPL, we have developed and 
optimised a peptide level labelling strategy called post-digest ICPL (Figure 1b), which 
allows for the tagging of the N-termini of all peptides, making them amenable to 
quantification (Leroy et al., 2010). This strategy is still currently used in our lab and has 
allowed for a significant number of successful analyses, some of which are presented below.  
While increasing the global amount of obtained quantitative data, labelling at the peptide 
level also implies that a highly cautious sample preparation technique must be employed to 
avoid bias introduction because samples will be mixed very late in the workflow process. It 
also impairs the possibility of protein-based sample fractionation, and a high resolution 
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peptide chromatographic separation (using 2D-LC) or high throughput data acquisition 
system will be required. It can be assumed that the earlier the sample labelling and mixing 
the lower the chance of bias introduction. Therefore, the best solution is to mix the samples 
even before protein extraction so that the chance of bias introduction is extremely decreased, 
and all protein fractionation methods can be easily applied to the sample. Such a procedure 
exists and is based on the introduction of a mass shift between the samples to be compared 
through the metabolic incorporation of isotope-coded amino acids during cell culture 
(Figure 1c; (Ong et al., 2002)). The two most common metabolic labelling are the 15N 
labelling, usually used for microorganisms (Li et al., 2007; Ting et al., 2009) whereas the 
stable isotope labelling in cell culture (SILAC) is mostly used for mammalian cells (Ong et 
al., 2002; Mann et al., 2006). This method SILAC allows all tryptic peptides to be labelled and 
quantified if lysine and arginine are used as the isotope-coded amino acids. During such a 
workflow, harvested cells from treated samples versus control can be mixed immediately 
and extracted together, which ensures a perfectly unbiased sample treatment. Obviously, all 
methods suffer from some limitations. This method is only practical for auxotrophically 
cultivable organisms. Therefore, most bacteria as well as tissue samples are excluded from 
this workflow (Bantscheff et al., 2007). Recently, metabolically-labelled mice have been 
introduced to the market, which makes it possible to perform some tissue analyses using 
this type of workflow (Wu et al., 2004). 
As an alternative to chemical (ICAT, ICPL, etc.) and metabolic (SILAC, 15N, etc.) non-
isobaric labelling, the enzymatic introduction of isotopic differences between samples has 
also been developed. In this case, the hydrolysis of the peptide bond during enzymatic 
digestion is realised in presence of regular water for one sample but with 18O-containing 
water for the second sample, which results in the exchange of 2 16O for 2 18O at the C-
terminus of the produced peptide in the latter case (Ye et al., 2009). A 4-Da mass shift will be 
introduced and used to discriminate between peptides originating from samples that are to 
be compared. This method is very straightforward, but differences in the rate of oxygen 
exchange between different peptides are sometimes problematic. 
Most non-isobaric labelling strategies were developed as duplex strategies in which two 
samples can be compared. In order to increase analytical throughput, multiplexing is being 
introduced, notably with an ICPL tag (SERVA) for which a triplex and a quadruplex version 
were recently released. In this new version, the introduced mass shift is only 2 Da, and triply 
charged peptides will only be separated by 0.66 m/z. Under low resolution, such as using 
an ion trap mass spectrometer, the isotopic pair will become difficult to discriminate, and 
multiplexing sample analyses using non-isobaric labelling definitely require a high 
resolution mass spectrometer. On the other hand, a multiplexing capability is clearly an 
advantage of isobaric labelling strategies in which it can be more easily implemented. 
3.1.2 Isobaric labelling 
ITRAQ has been described by Ross and co-workers (Ross et al., 2004). Here, low mass 
reporter ions produced after peptide fragmentation in a mass spectrometer are used for 
quantifications (Figure 1). In this low mass range, the 1-Da mass shift between the singly 
charged reporter ions is easily discriminated and can be used for quantification, even with a 
low resolution instrument. This facilitates multiplexing analysis and, hence, ITRAQ exists in 
a 8-plex version and TMT (tandem mass tag; (Dayon et al., 2008) exists in a 6-plex version. 
This multiplexing capability undoubtedly represents a major advantage of isobaric labelling 
www.intechopen.com
Gel-Free Proteome Analysis Isotopic Labelling  
Vs. Label-Free Approaches for Quantitative Proteomics 333 
because as many as 4 pairs of control/case samples can be simultaneously analysed. 
Alternatively, multiplexing can be used to perform technical replicates at the same time to 
increase the statistical power of the dataset. To date, ITRAQ represents the most commonly 
used quantification strategy with more than 500 entries found in a Pubmed bibliographic 
search engine using the keyword "ITRAQ" versus less than 350 for "SILAC". As in the post-
digest ICPL, ITRAQ and TMT rely on peptides labelled at their N-termini due to an amine 
reactive group and also allows for the quantification of all identified peptides. Nevertheless, 
ITRAQ also has its own limitations, mainly due to the necessity of analysing a low mass 
range of the MS/MS spectra, which is generally not performed using a quadrupole /ion 
trap mass spectrometer. 
Non-isobaric labelling also presents another advantage over isobaric tagging, i.e., the ability 
to include differences in relative abundances for an isotopic pair in the precursor selection 
criteria to determine which ion will be selected for fragmentation. In other words, the mass 
spectrometer could preferentially select peptides for which a differential abundance has 
been detected and can virtually decrease the sample complexity and focus on the 
differentially abundant proteins. This is obviously not possible with isobaric tags because 
quantitative data are only available after precursor selection and fragmentation have 
occurred.  
3.1.3 Examples of isotopic labelling applications 
The major benefit of using isotopic labelling workflow in differential proteomics is the high 
accuracy of the obtained quantitative data. As discussed below, isotopic labelling definitely 
surpasses label-free approaches in this aspect. In this section, we will emphasise case studies 
in which high precision data were obtained and validated using alternative methods. 
In our lab, we are currently involved in the analysis of naive T cell activation through anti-
CD3/CD28 in the presence or absence of co-activating interleukins, notably IL-6. This 
project aims to better understand the mechanisms that underlie T cell differentiation, 
particularly T follicular helpers (Eddahri et al., 2009). In this study using post-digest ICPL 
and 2D-LC MS/MS, some obvious markers of Th2 polarisation of IL6-activated T cells were 
detected, as was expected (unpublished data). In addition, slight differences were also 
observed for proteins related to cellular trafficking. As T cell cellular trafficking is already 
known to be important for T cell differentiation (Tanaka et al., 2007), the validation of these 
observations is essential. We are focusing our efforts on a microtubule (Mi) polymerisation 
factor for which only a slight increase of abundance could be observed in IL6-activated T 
cells. The fold change observed in two biological replicates were only 1.33 and 1.48 with 2 
and 5 peptides being used for quantification, respectively (Figure 2). This protein was 
selected because its means fold change (calculated on the 2 biological replicates) was 
statistically different from 1 based on t-student analysis (t <0.05). Western blot analysis was 
used to quantify the relative abundance of this protein on a third biological replicate using 
image based quantification (Figure 2). A fold change of 1.4, obtained by western blotting, 
confirmed the accuracy as well as the reproducibility of the observation made using post-
digest ICPL.  
A second example comes from the analysis of the fear-conditioning influence on neuronal 
plasticity. In this context, fear-conditioned rat cerebral tissue was compared to 
unconditioned controls using post-digest ICPL and 2D-LC MS/MS. In this analysis, the 
abundance of very few proteins was altered between the samples and control and only very  
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Fig. 2. Western blot analysis was used to validate the data obtained by post-digest ICPL. C : 
control; Mi, Microtubules; SD(geo), geometric standard deviation. 
 
 
Fig. 3. Western blot analysis was used to validate data obtained by post-digest ICPL.  
Mbp: Myelin basic protein 
slight changes were observed (unpublished data). Among the three biological replicates 
analysed, a protein was always modified with the same fold change of around 0.75 (Figure 
3, t <0.05), which meant a slightly lowered abundance in the fear-conditioned animals. As 
this protein is known to be related to neuronal plasticity, it was mandatory to be able to 
confirm the 2D-LC MS/MS-obtained data. Here, again using a western blot (Figure 3), this 
protein has been selected for validation, which made it possible to confirm, after image-
based quantification, a 30% decrease in the abundance of this protein. 
The third example has been recently published by a Finnish group and is also related to the 
T cell differentiation mechanism but in presence of an alternative interleukin, namely IL4 
(Moulder et al., 2010). In this study, the nuclear fraction was analysed 6 and 24 hrs after IL4 
supplementation or control anti-CD3/CD28 activation of naive T cells. As observed in our 
study, the differences between the IL4-activated cells and control activation were very scarce 
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and of a low amplitude. Moulder and co-workers considered 3 biological replicates, and all 
were analysed three times using an ITRAQ 4-plex kit. In this study, a random effect meta-
analysis model was used to estimate the representative expression ratios for each protein. 
Thanks to this elaborate study design they were able to apply a fold change cut-off of 1.2 (a 
20% abundance variation) to their dataset and highlight abundance modifications for 
important proteins. Moreover, their observations can also be confirmed by fluorescence-
based western blot analysis. 
Finally, there is another example of a very well-designed study in which ITRAQ was 
proven to be highly reproducible. Uwin and co-workers (Unwin et al., 2006) analysed the 
differences in proteomes of two lineages of stem cells LSK+ (Lin+, Sca+, Kit+) and LSK- 
(Lin-, Sca+, Kit-) and also applied a cut-off of 1.2 to their obtained dataset, even though 
only 2 biological replicates were analysed. The use of such a low fold change threshold 
was justified by filtering their dataset based on intra-condition variability limits. Indeed, a 
4-plex ITRAQ kit was used to label and analyse the two LSK+ biological replicates 
together and the two LSK- biological replicates. For a protein to be considered of a 
different abundance, the LSK+1 vs. LSK+2 as well as the LSK-1 vs. LSK-2 ratios of that 
protein had to first be between 1.10 and 0.92 (minimal intra-condition variability), and in 
addition, both the LSK+1 vs. LSK-1 and LSK-2 and LSK+2 vs. LSK-1 and LSK-2 ratios had 
to be higher than 1.2 with a p<0.05 in a pairwise Student’s t-test analysis. This analysis 
clearly indicates the very high value of the multiplexing capability of isobaric labelling 
workflow and the extreme accuracy of the quantitative data that can be obtained using 
isotopic labelling strategies. 
3.2 Label-free approaches 
Label-free approaches fundamentally demonstrate that a MS signal observed for a peptide 
correlates very well with its abundance in the sample (Chelius and Bondarenko, 2002). A 
difficulty arises from the effect of the matrix, which may differ between the two separate 
LC MS/MS runs, and thus impair a fair comparison of the data sets acquired 
consecutively. Bondarenko and co-workers (Bondarenko et al., 2002) were the first to 
demonstrate that such a comparison of MS signals between individually acquired datasets 
was possible even with complex protein mixtures like serums. Thus, it appears that if a 
chromatographic separation is sufficiently controlled, the matrix effect is not that different 
between successive runs, and MS data can be used to quantify MS/MS- identified 
peptides (Figure 1g).  
In addition, relying on the assumption that the matrix effect can be controlled, other 
approaches for label-free protein abundance comparisons have been described that rely on 
MS/MS data. Indeed, Liu et al. (Liu et al., 2004) demonstrated that the number of MS/MS 
spectra acquired by LC MS/MS for a defined protein correlates over 2 orders of magnitude 
with its abundance in the sample (Figure 1h). This very simple measurement relies on the 
principle that the more we see a protein the more abundant it should be in the sample. This 
type of strategy is termed spectral counting and can be opposed to "MS spectral intensity 
measurements" as "MS/MS features analyses". 
3.2.1 MS-based label-free analysis 
Since the first demonstration of the linearity of the MS signal and protein abundance 
relationship by Chelius and Bondarenko (Chelius and Bondarenko, 2002) as well as Wang 
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and co-workers (Wang et al., 2003), who performed a large scale demonstration of the 
applicability of this finding on large numbers of samples, MS-based label-free analyses 
have continuously been optimised and used more frequently in biological studies and 
especially in clinical research. Although sample preparation and MS data acquisition must 
be performed very cautiously as they represent a mandatory step, processing the data 
from a MS-based label-free approach is far for being trivial. Indeed, for all ions to be 
quantified, an area under the curve (AUC), based on the m/z and chromatographic 
retention time of the ion, has to be determined for all samples. Even with the best 
chromatographic system, this step will first necessitate a realignment of multiple 
chromatograms to compensate for the long analysis-induced retention time drift. This 
aspect is critically dependent on the quality of the chromatographic system and in 
particular, on its stability. The implementation of an ultra-HPLC system presenting 
excellent stability in terms of retention time now alleviates this step and will probably 
become mandatory to achieve a high quality MS-based label-free quantitative analysis. 
Once the chromatograms are suitably aligned, the AUC can be calculated for a particular 
ion based on its measured m/z. Of course, the accuracy of the data will depend on the 
ability to calculate the AUC for particular peptides and to avoid contamination by co-
eluting peptides with similar m/z values. In that aspect, mass spectrometric resolution is 
critical and can help narrow the AUC calculation windows and, thus, eliminate most of 
the contaminating signal (figure 4). 
 
 
 
 
Fig. 4. High resolution mass spectrometry allows AUC calculations based on narrow m/z 
windows. In the case of co-eluting peptides of similar m/z values (left panel), the calculated 
AUC can be very different if narrow m/z windows (0.05; right lower panel) are used or if 
larger m/z windows (0.15; right higher panel) are taken into account due to a lower mass 
spectrometer resolution. Personal data obtained using the Triple TOF5600 (ABSciex). 
A large amount of software has been developed for MS-based label-free quantification, and 
new tools are frequently released, which indicates a keen interest in these methods. A 
description of these softwares is beyond the scope of this chapter and has recently been 
performed by Neilson et al. (Neilson et al., 2011). However, it is interesting to note a 
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dichotomy in MS-based label-free data processing strategies. Indeed, if most of the early 
implemented data processing tools relied on an identified peptide list for AUC calculation, 
software now exists that allows for an unbiased total ion quantification independent of 
positive identification during the database search process. Quantitative data are calculated 
for all detected m/z notwithstanding an identified ion or even selected for fragmentation. 
Such an approach allows for the circumvention of a low sampling drawback of data-
dependent acquisition in MS, which generally results in missing low level peptides. Here, all 
detectable ions are quantified and ions for which differential abundances have been 
observed can be identified by a subsequent targeted analysis. Obviously, as in this case, a 
quantification step only relies on accurate masses and RT measurements (AMRT or AMT 
workflow) without prior confirmation by MS/MS, such a workflow is only applicable to 
high resolution mass spectrometry-based platforms. 
Another way to address the sampling bias of data-dependent acquisition has been proposed 
by Plumb and co-workers (Plumb et al., 2006). These authors developped the first real data- 
independent acquisition (DIA) workflow called MSE (E states for elevated energy) and is 
available as an acquisition mode with WATERS instruments. This strategy is aimed to 
obtain the fragmentation data for all detectable ions by avoiding precursor selection (as in 
data-dependent acquisition, DDA) and isolation and rather acquiring alternatively low and 
high collision energy mass spectra for a full mass range. Using multiple criteria, a 
tremendous algorithm is then charged to associate a precursor mass deduced from low 
energy spectra and its fragment ions obtained in the high collision energy spectra. The 
grouping of fragment ions with their parent ions mainly relies on intensity and the elution 
profile. This theoretically comprehensive quantification and identification of all detectable 
ions has triggered significant interest and already been used in numerous publications 
(Blackburn et al., 2010; Herberth et al., 2011; Mbeunkui and Goshe, 2011). A variant of this 
workflow has recently been implemented by ABSciex (MSAll) on its triple TOF5600, and it 
can be assumed that all MS vendors will implement a DIA-like workflow on their 
instruments. 
3.2.2 MS/MS-based label-free analysis 
MS/MS-based label-free derived data represent the simplest process to quantify 
information. Indeed, there is no need to align a chromatogram to calculate AUC or to detect 
isotopic pairs, and everything required is contained in the database search results. MS/MS-
based label-free quantification relies on the assumption that in data-dependent acquisition 
(DDA) analysis the sampling probability of a protein (i.e., the number of MS/MS spectra 
related to a protein) is a function of the protein’s abundance in the sample (Liu et al., 2004), 
which can be estimated by the so-called "spectral count" of a protein. MS/MS-based label-
free quantification has been diversified using different parameters such as peptide counts 
(the number of unique peptides; (Gao et al., 2003)), sequence coverage and several 
tentatively normalised indices (NSAF, Normalised spectral abundance factor, etc.;(Ishihama 
et al., 2005; Florens et al., 2006)).  
The accuracy of MS/MS-based label-free quantification has also been extensively 
investigated and proven unexpectedly high given the extreme simplicity of the 
measurement. In 2006, Zhang et al. (Zhang et al., 2006) compared spectral count, peptide 
count and sequence coverage in terms of reliability and also investigated the statistical 
relevance of such measurements. Interestingly, they linked the fold change, which can be 
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perceived statistically, with the actual number of spectral counts. This analysis showed that 
below 15 spectral counts only fold change higher than 2 could be detected no matter what 
statistical test was used. However, if more than 50 spectral counts were obtained, a fold 
change of 1.5 was detected. More recently, Colaert and co-workers (Colaert et al., 2011) 
estimated the global standard deviation of three different MS/MS-based label-free 
techniques and concluded that all of them had global SD of around 0.5. If a simple threshold 
in the format of mean +/- 2 SD is applied to such a dataset, fold changes higher than 2 were 
generally measurable.  
Spectral counting has also been modified to allow for comparisons of the abundances of 
different proteins and absolute quantification. emPAI (exponentially modified protein 
abundance index) normalises the number of identified peptides of a protein by the number 
of theoretically observable peptides to account for differences in sequence characteristics 
between different proteins and allows for their quantitative comparison. More recently, 
APEX (absolute protein expression; (Lu et al., 2007)) profiling was developed to measure the 
absolute protein concentration per cell from the proportionality between the protein 
abundance and the number of peptides observed, by using a correction factor that correlates 
the likelihood of peptides observed to their intrinsic characteristics (length, amino acid 
composition, etc.). 
3.2.3 Examples of label-free analysis 
Recently, we had the opportunity to challenge the label-free analytical platform from 
WATERS using the ion mobility-implemented synapt G2 mass spectrometer (unpublished 
data) and its MSE data-independent acquisition features. We analysed three biological 
replicates of crude protein extracts from Variovorax sp. SRS16 cultured in the presence or 
absence of the phenylurea herbicide linuron. This strain has already been shown to 
catabolise linuron (Breugelmans et al., 2007), and we have already performed gel-based 
(Breugelmans et al., 2010) as well as isotopic labelling gel-free proteomic analyses on these 
samples (Bers et al., In Press), indicating us what changes should be expected. All three 
biological replicates were injected three times, and only proteins identified in at least 2 out 
of the 3 technical replicates as well as in each biological replicate were considered for 
quantification. A statistical analysis was performed on the mean linuron/control ratio 
and, thus, only proteins with a rejected null hypothesis (ratio = 1) and a p-value <0.05 
were accepted as modified in abundance. An arbitrary cut-off of 1.5 and 0.66 was 
additionally applied. Using these stringent criteria (identification in all three biological 
replicates and in at least 2 out of 3 technical replicates with a p-value <0.05), 83 proteins 
(33 up, 50 down) out of the 1500 identified were considered to differ in amount between 
the linuron and control condition. This label-free analysis gives us a tremendous increase 
in proteome coverage, multiplying the number of detected and quantified proteins by a 
factor of 3. 
A particular feature of label-free analysis is its higher throughput, which facilitates large 
sample size analysis in clinical research and biomarker discovery. Moon and co-workers 
(Moon et al., 2011) recently used a MSE-based label-free strategy efficiently in order to 
discover biomarker candidates. From the urinary exosome proteome of IgA nephropathy 
(IgAN), thin basement membrane nephropathy (TBMN) and healthy patients, they were 
able to identify and quantify more than 1800 proteins, among which 83 differed in amount 
between IgAN and TBMN. Four IgAN/TBMN-discriminating biomarkers were selected 
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among this dataset (aminopeptidase N, vasorin precursor ceruloplasmin and alpha-1-
antitrypsin). These candidate biomarkers were submitted to western blot analysis on an 
independent set of samples, which failed to confirm differential expression for one of them 
but was validated in the other three. ROCs for differentiation between IgAN and TBMN 
indicated a high potential use for ceruloplasmin in this context because it provided a 
specificity of 91% for a sensitivity of 100%. 
Using spectral counting, Saydam and co-workers (Saydam et al., 2010) recently analysed 
differences between human meningioma cells and primary arachnoidal cells. Proteins were 
separated by SDS-PAGE, the gels were cut into ten bands, submitted to in-gel digestion and 
the peptides were analysed by LC MS/MS. For all identified proteins, the spectral count was 
determined, and the differences between the samples were evaluated for statistical 
relevance using beta-binomial test. In this very simple workflow, 2800 proteins were 
identified (protein prophet probability >99% and at least 2 peptides), and 10% of them were 
statistically different in amount between the archnoidal cells and meningioma. Proteins 
belonging to the minichromosome maintenance (MCM) family were observed in a higher 
abundance in meningioma cells and were submitted for further validation by qRT-PCR and 
western blotting.  
4. Isotopic labelling or label-free approaches? 
4.1 Relative quantification 
Most proteomic studies aim to compare different states of a proteome rather than obtaining 
absolute quantitative data. When designing such a differential proteomic analysis, one has 
to face, with Cornelian dilemma, the question of which method would be most suitable for 
obtaining valuable data useful for better characterising a biological system. This is a very 
difficult and important topic for which many parameters must be considered. In the above 
section, we have tried to describe and exemplify the main existing methods for relative 
comparisons of protein abundances. Here, we will try to summarise, based on their pros and 
cons, which methods best suit which needs. 
A first principle could be to use the most straightforward and simple method possible. In 
regards to this aspect, MS/MS-based label-free analysis clearly comes first. This method 
only requires that sample preparation and data acquisition are reproducible, which is 
usually expected. Here, there is no requirement for time-consuming sample labelling or 
for an analytical platform using ultra-HPLC and high resolution MS. This type of analysis 
can be applied to a variety of samples, such as very large sample cohort, often required 
for clinical research, and no limitation exists concerning the number of conditions that can 
be compared at a time. Finally, assuming a convenient correction factor is used, absolute 
quantitative data can be obtained, which allows not only for a comparison of the 
abundance of a protein in different samples, but also ranks the proteins in a defined 
proteome based on their abundance (Mastroleo et al., 2009a). Of course, as no ideal 
method exists, a MS/MS-based label-free approach also has a major drawback, data 
accuracy. As already described above, numerous analyses have been conducted to 
estimate this accuracy and concluded this technique does not easily detect fold changes 
lower than 2 (Zhang et al., 2006; Colaert et al., 2011). Nevertheless, it is important to 
replace this accuracy in the context of a biological question. Indeed, if only major changes 
are of interest or if the samples to be compared are expected to be highly different, 
MS/MS-based quantitative data could be sufficient. Equivalently, if one goal is to 
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discover biomarker candidates able to discriminate diseased from healthy patients, it is 
not mandatory to be able to detect very slight fold changes. On the contrary, only proteins 
presenting major differences between controls and clinical cases will ultimately be useful 
for physicians to help them in their diagnostics or prognostics. It appears that pure 
biomarker discovery studies can be typically performed using MS/MS-based label-free 
approaches, and a more elaborate workflow would only be helpful if functional data 
could also be gained or are needed. 
If not only discriminative but also functional data are to be obtained, acquiring accurate 
quantitative data is absolutely required. In these cases, both MS-based label-free approaches 
and isotopic labelling could be suitable. Nevertheless, the pros and cons of both strategies 
can help in the decision. 
First, MS-based label-free techniques are only able to reach the isotopic labelling accuracy of 
quantitative data (CV>20%) if the analyses are performed on the latest generation mass 
spectrometers. Although MS vendors are continuing their efforts to allow access to such 
pieces of equipment to an increasing number of labs, to date, they are not considered as a 
benchtop device that is easily handled and accessible. On the other hand, isotopic labelling 
is easily amenable to high accuracy studies using a first generation Q-TOF device, or 
quadrupole ion trap. 
The number of conditions to be analysed needs to be carefully considered. Indeed, isotopic 
labelling is limited in its multiplexing capacity, since so far only TMT and iTRAQ allow the 
comparison of multiple (up to 6 and 8 respectively) samples at the same time. For non-
isobaric labelling, multiplexing capacities are, to date, limited at 4 samples, and in this case 
again, high resolution MS would be required. 
Analysis throughput is generally considered to be lower when isotopic labelling is used 
because 2D-LC peptide separation is usually necessary to avoid the co-elution of peptides 
with similar m/z values, which might introduce errors in quantification. Label-free 
approaches, which rely on high resolution MS systems and ultra-HPLC, generally more 
efficiently deal with co-eluting peptides with similar m/z values and can be performed 
using 1D-LC. Nevertheless, it must be kept in mind that if the analysis of two mixed 
samples using 2D-LC requires around 12 hours, no gain in machine time will be obtained if 
the same samples are analysed using a 2-hour gradient in 1D-LC because, to obtain 
statistical relevance using data from a label-free analysis, a triplicate injection of all samples 
is generally required. 
Another advantage of isotopic labelling is that when tagging occurs at the protein or even 
at the cell culture level, such as in SILAC, samples can be mixed very early in the 
workflow, and, thus, potential biases are avoided. During label-free approaches, full 
sample processing is performed separately, and the risk of a biased treatment is obviously 
increased. 
In some cases, a high accuracy will not be sufficient and ultimate precision will be 
required. This is the case if very slight modifications are expected, such as in the example 
of T cell differentiation we have highlighted above. Post-translational modifications of 
proteins can also dramatically change a protein’s function even if the fold changes are 
extremely small. In regards to this aspect, isotopic labelling still surpass label-free 
approaches and is the method of choice if fold changes lower than 1.4 must be efficiently 
characterised, as described above. 
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4.2 Absolute quantification 
It has already been described that MS/MS-based label-free approaches can be used to 
reach an absolute quantification, but here again the precision is generally low and only 
orders of magnitude can be determined. Isotopic labelling is more easily amenable to the 
accurate absolute quantification of targeted proteins in a MS workflow. Absolute 
quantitative methods aim to measure the absolute protein level using a standard peptide 
to the corresponding protein. This is achieved by mixing a known amount of the 
synthesized isotope-coded form of a peptide from the protein to be quantified and using it 
as an internal standard to calculate the endogenous amount of the protein (method 
AQUA, Absolute quantification) (Gerber et al., 2003). This principle has been diversified 
in order to multiplex the proteins being quantified as well as to decrease biases 
introduced during sample treatment. In a new workflow termed concat, a chimeric 
protein composed of concatenated isotope-coded peptides to be quantified is introduced 
in the sample before enzymatic digestion. The common enzymatic digestion of reference 
peptides and endogenous peptides ensures a higher accuracy and allows for easy 
multiplexing. 
Until recently, MS-based label-free approaches did not support absolute quantification. 
Nevertheless, Silva and co-workers from WATERS Corporation (Silva et al., 2006) reported 
that MSE was the most accurate label-free technique for estimating absolute abundance by 
using average of the three most abundant tryptic peptides, which was reported to be 
proportional to protein molarity. This discovery used a unique internal standard to obtain 
absolute quantitative data for 6 exogenous standard proteins spiked into serum with a 
relative error below 15%. Moreover, 11 proteins of the serum matrix could also be 
quantified, and the obtained data correlates very well with the values available in the 
literature. To date, this absolute quantification feature has, to our knowledge, only been 
implemented in WATERS software packages. 
5. Conclusion 
In this chapter, we have described the most widely used strategies for quantitative 
proteomics studies. All have their pros and cons, which makes the choice of one of them 
difficult for non-proteomic researchers. Different criteria can be used in order to 
distinguish which method is best-suited to a given biological question. Among these, the 
data accuracy level required is probably the most interesting. With numerous proteomic 
analyses focusing on biomarker discovery, MS/MS-based label-free workflows are, to 
date, underutilised. When accurate data must be obtained, isotopic labelling methods and 
label-free approaches work equally well. Isotopic labelling will nevertheless still be of 
interest when high precision is required. It is expected that, in the future, easier access and 
development of highly reproducible nano-HPLC separation, high resolution mass 
spectrometer, and efficient computational tools will greatly improve the reliability and the 
use of label-free workflows. 
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